Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TAPI Czech Industries, a division of Teva Pharmaceutical Industries, is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) located in Opava, Czech Republic. The facility specializes in the development and large-scale production of complex APIs, including high-potency compounds, synthetic peptides, and fermentation-based products. With a history dating back to the 1883 founding of Galena, the site is a cornerstone of Teva's global supply chain and one of the largest pharmaceutical employers in the region. The company provides high-quality ingredients for a wide range of therapeutic areas, including oncology, central nervous system disorders, and cardiovascular health. Operating under strict global regulatory standards, TAPI Czech Industries supports both the parent company's portfolio and external third-party pharmaceutical clients. The site also features significant R&D capabilities focused on process optimization and the development of new chemical entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TAPI Czech Industries.